IRIS
DE LUCA, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.720
EU - Europa 5.575
AS - Asia 1.358
SA - Sud America 10
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 13.679
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.690
IE - Irlanda 1.747
SE - Svezia 1.424
CN - Cina 845
UA - Ucraina 679
IT - Italia 524
DE - Germania 444
FI - Finlandia 289
GB - Regno Unito 206
VN - Vietnam 197
IN - India 160
SG - Singapore 122
CZ - Repubblica Ceca 68
BE - Belgio 50
RU - Federazione Russa 49
CA - Canada 28
FR - Francia 27
AT - Austria 24
PL - Polonia 14
IR - Iran 12
NL - Olanda 10
JP - Giappone 7
CL - Cile 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BR - Brasile 4
GR - Grecia 4
PK - Pakistan 4
RO - Romania 4
CH - Svizzera 3
EG - Egitto 3
HU - Ungheria 2
KR - Corea 2
LV - Lettonia 2
MA - Marocco 2
NZ - Nuova Zelanda 2
PH - Filippine 2
TR - Turchia 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
DZ - Algeria 1
EE - Estonia 1
ES - Italia 1
EU - Europa 1
HK - Hong Kong 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 13.679
Salva come PNG Salva come JPEG
Città #
Dublin 1.745
Chandler 1.328
Jacksonville 1.325
Nyköping 952
Ashburn 409
Beijing 395
Princeton 297
Medford 258
Cambridge 256
Dearborn 256
Des Moines 226
Dong Ket 186
Messina 184
Boardman 170
Ann Arbor 158
Hyderabad 87
Wilmington 82
Woodbridge 79
Singapore 70
Lancaster 69
Pune 59
Brno 56
Jinan 56
San Mateo 52
Shenyang 51
Los Angeles 49
Brussels 46
Nanjing 45
Munich 40
Catania 37
Haikou 33
Lappeenranta 30
Hebei 29
Seattle 29
Taizhou 26
Hangzhou 23
Vienna 23
Ningbo 21
Francofonte 20
Tianjin 20
Washington 19
Fuzhou 17
Norwalk 16
Saint Petersburg 16
Zhengzhou 16
Milan 15
Nanchang 15
Ottawa 14
Warsaw 13
Guangzhou 12
Houston 12
New York 12
Olomouc 12
Taiyuan 12
Jiaxing 11
Falls Church 10
Helsinki 10
Leawood 10
Rome 10
Clearwater 9
Frigento 9
Ho Chi Minh City 9
Kunming 8
London 8
Montréal 8
Palermo 8
Changsha 7
Nicotera 7
Borghetto Santo Spirito 6
Brooklyn 6
Chicago 6
Mcallen 6
Monmouth Junction 6
Nuremberg 6
Ardabil 5
Auburn Hills 5
Augusta 5
Hefei 5
Phoenix 5
Florence 4
Lanzhou 4
Mumbai 4
Riva 4
West Jordan 4
Amsterdam 3
Bremen 3
Brugherio 3
Cairo 3
Como 3
Edinburgh 3
Fidenza 3
Genoa 3
Hanover 3
Monreale 3
Nanning 3
Paris 3
Siena 3
Stockholm 3
Tappahannock 3
Toronto 3
Totale 9.731
Salva come PNG Salva come JPEG
Nome #
1,3-diidro-benzimidazoloni analoghi: progettazione, sintesi e SAR di nuovi inibitori non-nucleosidici dell'RT 195
1,3-THIAZOLIDIN-4-ONES:POTENT AND HIGHLY SELECTIVE ANTI-HIV-1 AGENTS 151
1,3-Thiazolidin-4-ones: potent and selective anti-HIV-1 agents 145
Chemical exploration of 4-(4-fluorobenzyl)piperidine fragment for the development of new tyrosinase inhibitors 96
Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases 91
AMPA receptor antagonists: Synthesis and pharmacological evaluation 90
Vitamin D: a steroid hormone with progesterone-like activity 89
Seeking new approach for therapeutic treatment of cholera disease via inhibition of bacterial carbonic anhydrases: experimental and theoretical studies for sixteen benzenesulfonamide derivatives 88
Targeting Tyrosinase: Development and Structural Insights of Novel Inhibitors Bearing Arylpiperidine and Arylpiperazine Fragments 86
Nuovi Antagonisti Non-Competitivi Del Recettore NMDA/NR2b: Design e Sintesi” 78
Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms 78
Graphene Quantum Dots Based Systems As HIV Inhibitors 78
Modificazioni strutturali del gruppo dichetoacido (DKA) di potenti inibitori dell'Integrasi dell'HIV-1 77
Synthesis and anti-HIV activity of carboxylated and drug-conjugated multi-walled carbon nanotubes 73
Looking toward the Rim of the Active Site Cavity of Druggable Human Carbonic Anhydrase Isoforms 71
HIV-1 integrase strand-transfer inhibitors: Design, synthesis and molecular modeling investigation 70
Exploiting the 1-(4-fluorobenzyl)piperazine fragment for the development of novel tyrosinase inhibitors as anti-melanogenic agents: Design, synthesis, structural insights and biological profile 70
1-Benzylpiperidine derivatives: design and synthesis of new compounds as tyrosinase inhibitors from Agaricus bisporus 70
Anti-HIV agents: design and discovery of new potent RT inhibitors 68
Synthesis, biological evaluation and docking studies of NR2B/NMDA receptor antagonists 68
Design and optimization of isoquinoline-sulfonamides as potent and selective inhibitors of human carbonic anhydrase VII 68
Structure-activity hypothesis in the design of new AMPA receptor antagonists. 66
DISCOVERY OF NEW INDOLE DERIVATES AS NEUROPROTECTIVE AGENTS 66
In Silico-Guided Identification of New Potent Inhibitors of Carbonic Anhydrases Expressed in Vibrio cholerae 66
Synthesis, resolution, stereochemistry, and molecular modeling of (R)- and (S)-2-acetyl-1-(4 '-chlorophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline AMPAR antagonists 65
InVivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 65
Progettazione Sintesi e SAR di nuovi derivati tetraidroisochinolinici. 64
Anticonvulsant agent: enhancement of physicochemical properties 64
Small molecules targeting the interaction between HIV-1 integrase and LEDGF/p75 cofactor. 64
Merging lithium carbenoid homologation and enzymatic reduction: A combinative approach to the HIV-protease inhibitor Nelfinavir 64
Binding modes of noncompetitive AMPA antagonists: a computational approach 63
Analysis of the full-length integrase-DNA complex by a modified approach for DNA docking 63
Nuovi ligandi del recettore NR2B/NMDA a struttura indolica 63
The 1-(4-fluorobenzyl)piperazine fragment for the development of novel tyrosinase inhibitors 63
Combined strategies for the discovery of ionotropic glutamate receptor antagonists 62
Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as Potent Carbonic Anhydrase Inhibitors: Synthesis, Biological Evaluation, and Enzyme−Ligand X-ray Studies 62
Synthesis and structure-active relationship of 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline anticonvulsants 62
Small Molecules Targeting Protein–Protein Interactions: A Promising Anti-HIV Strategy 62
Serendipitous discovery of indole derivatives as potent tyrosinase inhibitors 62
3D Pharmacophore model and synthesys of NMDA receptor subunit NR2B antagonists 61
A refined pharmacophore model and optimization of 1H-benzylindole HIV-1 integrase inhibitors 61
Synthesis of new pyridazine derivatives as potential anti-HIV-1 agents 61
Searching for indole derivatives as potential mushroom tyrosinase inhibitors 61
NOVEL N1-ARYL-2- ARYLTHIOACETAMIDOBENZIMIDAZOLES WERE EFFECTIVE AGAINST HERPES SIMPLEX VIRUS 1 (HSV-1) REPLICATION IN VITRO 61
Discovery of potent and selective inhibitors of druggable carbonic anhydrase isoforms 60
Inhibitors of the Interactions between HIV-1 IN and the Cofactor LEDGF/p75 60
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 59
AMPA Receptor Antagonists as Potential Anticonvulsant Drugs 59
Efficient 3D Database screening for novel HIV-1 IN inhibitors 59
Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety 59
4-Fluorobenzylpiperazine-Containing Derivatives as Efficient Inhibitors of Mushroom Tyrosinase 59
Binding mode prediction of Strand Transfer HIV-1 Integrase Inhibitors using Tn5 transposase as a plausible surrogate model for HIV-1 Integrase 58
A New 3D Pharmacophore Model for HIV-1 Integrase Strand Transfer Inhibitors 58
Identification of isoquinoline-sulfonamides as potent and selective carbonic anhydrase inhibitors 58
Discovery and optimization of isoquinoline-derived inhibitors of human Carbonic Anhydrases (hCAs) 58
Simulated human digestion of N1-aryl-2-arylthioacetamidobenzimidazoles and their activity against Herpes-simplex virus 1 in vitro 58
The link between the AMPK/SIRT1 axis and a flavonoid-rich extract of Citrus bergamia juice: A cell-free, in silico, and in vitro study 58
Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents 57
A New 3D Pharmacophore Model for HIV-1 Integrase Strand Transfer Inhibitors. 57
Sviluppo di modello farmacoforico predittivo per gli NR2B antagonisti del recettore NMDA 57
Antiretroviral strategy using multi-target agents 57
Successful optimization of human carbonic anhydrase inhibitors as neuroprotective agents 57
QSAR study of anticonvulsant negative allosteric modulators of the AMPA receptor 57
DISCOVERY OF 2,3-DIARYL-1,3-THIAZOLIDIN-4-ONES AS POTENT HIV-1 NNRTIS BY MOLECULAR MODELING STUDIES 56
Combined strategies for the discovery of ionotropic glutamate receptor antagonists 56
Searching for NR2B/NMDA Receptor Antagonists As Neuroprotective Agents 56
HIV-1 integrase strand-transfer inhibitors: design and synthetic strategies in the process of a lead optimization 56
New indole derivatives as promising ligands for ifenprodil site of NR2B/NMDA receptors 56
2-Hydroxyisoquinoline-1,3(2H,4H)-diones as inhibitors of HIV-1 integrase and reverse transcriptase RNase H domain: Influence of the alkylation of position 4 56
4-[1-(4-Fluorobenzyl)-4-hydroxy-1H-indol-3-yl]-2-hydroxy-4-oxobut-2-enoic acid as a prototype to develop dual inhibitors of HIV-1 integration process. 56
Probing the molecular interactions between the human Carbonic Anhydrases (hCAs) and a novel class of benzenesulfonamides 56
Design e sintesi di nuovi Antagonisti Noncompetitivi del Recettore AMPA 55
Design and Molecular Modeling Studies of HIV-1 RT Inhibitors 55
Novel Potent Anticonvulsant Agent Containing a Tetrahydroisoquinoline Skeleton. 55
Derivati benzimidazolonici ed analoghi come potenti inibitori non-nucleosidici dell'RT dell'HIV-1 55
Synthesis, computational studies and assessment of in vitro inhibitory activity of umbelliferon-based compounds against tumour-associated carbonic anhydrase isoforms IX and XII 55
Homology Modelling of AMPA Receptors: Route to the Identification of Noncompetitive Antagonists Binding Site 54
Sviluppo del modello DNA-integrasi dell'HIV-1: studi di docking e di dinamica molecolare 54
PROGETTAZIONE E SINTESI DI NUOVI DKA ANALOGHI COME POTENZIALI INIBITORI DELL’INTEGRASI DELL’HIV-1 54
Drug design and synthetic approach for the discovery of novel HIV-1 integrase inhibitors 53
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti- HIV-1 agents 53
Noncompetitive AMPA receptor antagonists: Synthetic approaches, molecular modeling and pharmacological profile 53
HIV-1 Integrase Inhibitors: Pharmacophore Modeling and Rational Drug Design 53
Computational Studies to Discover a New NR2B/NMDA Receptor Antagonist and Evaluation of Pharmacological Profile 53
Antiretroviral strategy: design and synthesis of HIV-1 IN-LEDGF/p75 interaction inhibitors 53
Molecular modeling e disign di inibitori dell'integrasi dell'HIV-1 52
Search fo non-competitive AMPA antagonists: Synthesis, pharmacological properties and computational studies 52
Antagonisti non-competitivi del recettore AMPA: progettazione, sintesi, SAR e studio del profilo farmacocinetico 52
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 52
From 3D-pharmacophore models to synthetic route towards anti-HIV agents 52
Design, Synthesis and SAR of New Potent HIV-1 RT Inhibitors”. Antiviral Research 52
Design and synthesis of 2,3-diaryl-1,3-thiazolidin-4one potent HIV-1 RT-inhibitors. 52
Discovery of potent HIV-1 integrase strand transfer inhibitors: design and synthetic strategies 52
Synthesis and anticonvulsant properties of 1,2,3,4-tetrahydroisoquinolin-1-ones 51
Combined ligand-based and target-based approach to design NR2B/NMDA receptor antagonists 51
6-Chloro-1-(3,5-dimethylphenylsulfonyl)-1H-benzimidazol-2(3H)-one 51
Progettazione e sintesi di antagonisti non competitivi del recettore NR2B/NMDA 51
A new potential approach to block HIV-1 replication via protein–protein interaction and strand-transfer inhibition 51
Rational design of small molecules able to inhibit α-synuclein amyloid aggregation for the treatment of Parkinson’s disease 51
A Combination of Pharmacophore and Docking-based Virtual Screening to Discover new Tyrosinase Inhibitors 51
Totale 6.432
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.961
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.961
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.704 0 167 8 156 5 250 273 212 30 263 327 13
2020/20211.894 215 6 335 72 79 204 19 223 65 238 154 284
2021/20221.854 32 284 33 74 81 29 164 63 39 69 373 613
2022/20235.220 402 449 237 450 387 510 108 274 2.141 15 185 62
2023/20241.333 97 202 96 246 117 223 24 45 5 116 29 133
2024/2025165 103 62 0 0 0 0 0 0 0 0 0 0
Totale 14.035